Access cutting-edge pediatric sarcoma treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access pediatric sarcoma specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pediatric sarcoma treatment provided free
The purpose of this study is to determine if the addition of infusions of a type of immune cell called a "natural killer", or NK cell to the sarcoma chemotherapy regimen GEM/DOX (gemcitabine and docetaxel) can improve outcomes in people with childhood sarcomas that have relapsed or not responded to prior therapies. The goals of this study are: * To determine the safety and efficacy of the addition of adoptive transfer of universal donor, TGFβ imprinted (TGFβi), expanded NK cells to the pediatr
Sponsor: Nationwide Children's Hospital
Check if you qualify for this pediatric sarcoma clinical trial in Palo Alto, CA
If you're searching for pediatric sarcoma treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric sarcoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.